Rapid Selection of Oseltamivir‐ and Peramivir‐Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts
Open Access
- 1 May 2010
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 50 (9), 1252-1255
- https://doi.org/10.1086/651605
Abstract
Pandemic 2009 H1N1 virus isolates containing the neuraminidase inhibitor resistance mutation H275Y have been reported. We describe rapid selection foKeywords
This publication has 15 references indexed in Scilit:
- Rapid Selection of a Transmissible Multidrug‐Resistant Influenza A/H3N2 Virus in an Immunocompromised HostThe Journal of Infectious Diseases, 2010
- Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009.2009
- Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.2009
- A Novel Neuraminidase Deletion Mutation Conferring Resistance to Oseltamivir in Clinical Influenza A/H3N2 VirusThe Journal of Infectious Diseases, 2009
- Pandemic and seasonal influenza: therapeutic challengesDrug Discovery Today, 2008
- Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivirAntiviral Research, 2007
- Characterization of Multidrug-Resistant Influenza A/H3N2 Viruses Shed during 1 Year by an Immunocompromised ChildClinical Infectious Diseases, 2006
- Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase InhibitorsAntimicrobial Agents and Chemotherapy, 2005
- Universal primer set for the full-length amplification of all influenza A virusesArchiv für die gesamte Virusforschung, 2001
- Position statement: global neuraminidase inhibitor susceptibility networkAntiviral Research, 2001